Tower Research Capital (TRC)’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | -$37 | – | 5261 |
|
|
2025
Q1 | $37 | Buy |
+1
| New | +$37 | ﹤0.01% | 5087 |
|
|
2024
Q3 | – | Sell |
-4
| Closed | -$602 | – | 5706 |
|
|
2024
Q2 | $602 | Sell |
4
-1
| -20% | -$151 | ﹤0.01% | 5293 |
|
|
2024
Q1 | $2.25K | Buy |
5
+1
| +25% | +$450 | ﹤0.01% | 5088 |
|
|
2023
Q4 | $3.09K | Hold |
4
| – | – | ﹤0.01% | 5127 |
|
|
2023
Q3 | $3.3K | Sell |
4
-5
| -56% | -$4.13K | ﹤0.01% | 5022 |
|
|
2023
Q2 | $8.92K | Sell |
9
-19
| -68% | -$18.8K | ﹤0.01% | 4335 |
|
|
2023
Q1 | $31K | Buy |
28
+4
| +17% | +$4.43K | ﹤0.01% | 2946 |
|
|
2022
Q4 | $16K | Buy |
24
+9
| +60% | +$6K | ﹤0.01% | 3323 |
|
|
2022
Q3 | $13K | Sell |
15
-7
| -32% | -$6.07K | ﹤0.01% | 4254 |
|
|
2022
Q2 | $18K | Sell |
22
-1
| -4% | -$818 | ﹤0.01% | 3885 |
|
|
2022
Q1 | $35K | Sell |
23
-7
| -23% | -$10.7K | ﹤0.01% | 3000 |
|
|
2021
Q4 | $38K | Buy |
30
+4
| +15% | +$5.07K | ﹤0.01% | 2996 |
|
|
2021
Q3 | $31K | Buy |
26
+4
| +18% | +$4.77K | ﹤0.01% | 3345 |
|
|
2021
Q2 | $18K | Buy |
+22
| New | +$18K | ﹤0.01% | 3979 |
|